Literature DB >> 33307105

Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α.

Amanda J Clark1, Samir M Parikh2.   

Abstract

The kidney has extraordinary metabolic demands to sustain the active transport of solutes that is critical to renal filtration and clearance. Mitochondrial health is vital to meet those demands and maintain renal fitness. Decades of studies have linked poor mitochondrial health to kidney disease. Key regulators of mitochondrial health-adenosine monophosphate kinase, sirtuins, and peroxisome proliferator-activated receptor γ coactivator-1α-have all been shown to play significant roles in renal resilience against disease. This review will summarize the latest research into the activities of those regulators and evaluate the roles and therapeutic potential of targeting those regulators in acute kidney injury, glomerular kidney disease, and renal fibrosis.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; diabetic nephropathy; fibrosis; mitochondria; proteinuria

Mesh:

Substances:

Year:  2020        PMID: 33307105      PMCID: PMC7987711          DOI: 10.1016/j.kint.2020.09.037

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  151 in total

1.  The application of electron microscopy and cellular biochemistry to the autopsy. Observations on cellular changes in human shock.

Authors:  B F Trump; J M Valigorsky; R T Jones; W J Mergner; J H Garcia; R A Cowley
Journal:  Hum Pathol       Date:  1975-07       Impact factor: 3.466

2.  Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK.

Authors:  Yong Soon Cho; Jae Il Lee; Dongkyu Shin; Hyun Tae Kim; Ha Yun Jung; Tae Gyu Lee; Lin-Woo Kang; Yeh-Jin Ahn; Hyun-Soo Cho; Yong-Seok Heo
Journal:  Biochem Biophys Res Commun       Date:  2009-11-10       Impact factor: 3.575

3.  Sirtuin 5 Regulates Proximal Tubule Fatty Acid Oxidation to Protect against AKI.

Authors:  Takuto Chiba; Kevin D Peasley; Kasey R Cargill; Katherine V Maringer; Sivakama S Bharathi; Elina Mukherjee; Yuxun Zhang; Anja Holtz; Nathan Basisty; Shiva D Yagobian; Birgit Schilling; Eric S Goetzman; Sunder Sims-Lucas
Journal:  J Am Soc Nephrol       Date:  2019-10-01       Impact factor: 10.121

4.  Nitrosporeusine A attenuates sepsis-associated acute kidney injury through the downregulation of IL-6/sIL-6R axis activation-mediated PGC-1α suppression.

Authors:  Yan Zhao; Ming Nie; Peng Xu; Hua Li; Lei Xu; Xue-Qi Cheng; Yan-Qing Lei
Journal:  Biochem Biophys Res Commun       Date:  2019-06-01       Impact factor: 3.575

5.  Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.

Authors:  Jinhua Li; Xinli Qu; Sharon D Ricardo; John F Bertram; David J Nikolic-Paterson
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.

Authors:  H-C Yang; L-J Ma; J Ma; A B Fogo
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

7.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

Authors:  J J Lehman; P M Barger; A Kovacs; J E Saffitz; D M Medeiros; D P Kelly
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

8.  Inhibition of PARP overactivation protects acute kidney injury of septic shock.

Authors:  Y-M Wang; R-L Han; S-G Song; X-P Yuan; X-S Ren
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-09       Impact factor: 3.507

9.  SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.

Authors:  Matthew D Hirschey; Tadahiro Shimazu; Eric Goetzman; Enxuan Jing; Bjoern Schwer; David B Lombard; Carrie A Grueter; Charles Harris; Sudha Biddinger; Olga R Ilkayeva; Robert D Stevens; Yu Li; Asish K Saha; Neil B Ruderman; James R Bain; Christopher B Newgard; Robert V Farese; Frederick W Alt; C Ronald Kahn; Eric Verdin
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

Review 10.  Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis.

Authors:  Noémie Simon; Alexandre Hertig
Journal:  Front Med (Lausanne)       Date:  2015-08-05
View more
  6 in total

Review 1.  Signaling pathways of chronic kidney diseases, implications for therapeutics.

Authors:  Qian Yuan; Ben Tang; Chun Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

2.  Identification of Structural and Molecular Signatures Mediating Adaptive Changes in the Mouse Kidney in Response to Pregnancy.

Authors:  Jorge Lopez-Tello; Maria Angeles Jimenez-Martinez; Esteban Salazar-Petres; Ritik Patel; Amy L George; Richard G Kay; Amanda N Sferruzzi-Perri
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

3.  Tourniquet-induced lower limb ischemia/reperfusion reduces mitochondrial function by decreasing mitochondrial biogenesis in acute kidney injury in mice.

Authors:  Balamurugan Packialakshmi; Ian J Stewart; David M Burmeister; Yuanyi Feng; Dennis P McDaniel; Kevin K Chung; Xiaoming Zhou
Journal:  Physiol Rep       Date:  2022-02

Review 4.  Organelle Stress and Metabolic Derangement in Kidney Disease.

Authors:  Reiko Inagi
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

5.  Ginsenoside Rg1 Ameliorates Acute Renal Ischemia/Reperfusion Injury via Upregulating AMPKα1 Expression.

Authors:  Qing Zhou; Xinlan He; Xiaoyu Zhao; Qigui Fan; Songqing Lai; Dan Liu; Huan He; Ming He
Journal:  Oxid Med Cell Longev       Date:  2022-09-01       Impact factor: 7.310

Review 6.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.